STOCK TITAN

HARMONY BIOSCIENCES ANNOUNCES DATE OF SECOND QUARTER 2022 FINANCIAL RESULTS

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Harmony Biosciences Holdings, Inc. (HRMY) will release its second quarter 2022 financial results on August 2, 2022. Following the release, a conference call and live webcast will occur at 8:30 a.m. ET. Investors can join the call by dialing (800) 459-5346 for domestic or +1 (203) 518-9544 for international, referencing passcode HRMYQ222. The live and replayed webcast will be accessible on the company's investor page. Harmony focuses on developing therapies for rare neurological diseases.

Positive
  • Scheduled financial results announcement for Q2 2022 on August 2, 2022.
  • Conference call and webcast provide transparency for investors.
Negative
  • None.

PLYMOUTH MEETING, Pa., July 19, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that it will issue a press release on the Company's second quarter 2022 financial results on Tuesday, August 2, 2022. Following the release, Harmony will conduct a conference call and live webcast on the same day, at 8:30 a.m. ET.

To participate in the call, please dial (800) 459-5346 (domestic) or +1 (203) 518-9544 (international), and reference passcode HRMYQ222. It is recommended that you dial in at least 10 minutes prior to the call.

The live and replayed webcast of the call will be available on the investor page of our website at https://ir.harmonybiosciences.com/.

About Harmony Biosciences 
At Harmony Biosciences, we specialize in developing and delivering treatments for rare neurological diseases that others often overlook. We believe that where empathy and innovation meet, a better life can begin for people living with neurological diseases. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, PA, our team of experts from a wide variety of disciplines and experiences is driven by our shared conviction that innovative science translates into therapeutic possibilities for our patients, who are at the heart of everything we do. For more information, please visit www.harmonybiosciences.com.

Harmony Biosciences Investor Contact:
Luis Sanay, CFA
445-235-8386
lsanay@harmonybiosciences.com

Harmony Biosciences Media Contact: 
Nancy Leone 
215-891-6046 
nleone@harmonybiosciences.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-announces-date-of-second-quarter-2022-financial-results-301588430.html

SOURCE Harmony Biosciences

FAQ

When will Harmony Biosciences announce its Q2 2022 financial results?

Harmony Biosciences will announce its Q2 2022 financial results on August 2, 2022.

What time is the Harmony Biosciences conference call for Q2 2022 results?

The conference call will take place at 8:30 a.m. ET on August 2, 2022.

How can I participate in the Harmony Biosciences Q2 2022 conference call?

To participate, dial (800) 459-5346 for domestic calls or +1 (203) 518-9544 for international calls and reference passcode HRMYQ222.

Harmony Biosciences Holdings, Inc.

NASDAQ:HRMY

HRMY Rankings

HRMY Latest News

HRMY Stock Data

1.91B
38.55M
11.62%
92.83%
10.62%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
PLYMOUTH MEETING